Polymer-based delivery systems offer versatile platforms for controlled, targeted, and sustained drug release. For B. Pharm students, understanding advantages and limitations of polymer-based delivery systems MCQs With Answer helps consolidate concepts like biodegradable polymers (PLGA, PLA, chitosan), mechanisms (diffusion, erosion, swelling), formulation techniques (emulsion-solvent evaporation, nanoprecipitation), and characterization parameters (encapsulation efficiency, particle size, zeta potential). Key advantages include protection of labile drugs, prolonged therapeutic effect, and site-specific delivery; limitations involve potential toxicity, burst release, stability challenges, and scale-up hurdles. This concise, keyword-rich introduction primes you for practical MCQs emphasizing formulation design, kinetics, and regulatory considerations. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is a primary advantage of using biodegradable polymers such as PLGA in drug delivery?
- Permanent implant formation in the body
- Controlled drug release through polymer degradation
- Guarantees zero-order release for all drugs
- Eliminates need for sterility
Correct Answer: Controlled drug release through polymer degradation
Q2. Which mechanism is NOT typically involved in drug release from polymer matrices?
- Diffusion through polymeric network
- Polymer erosion or degradation
- Swelling-controlled release
- Covalent drug evaporation
Correct Answer: Covalent drug evaporation
Q3. Encapsulation efficiency primarily measures which parameter?
- Particle size distribution
- Percentage of drug loaded versus total drug used
- Polymer molecular weight
- Surface charge of nanoparticles
Correct Answer: Percentage of drug loaded versus total drug used
Q4. Which polymer is commonly used for mucoadhesive oral drug delivery due to its positive charge?
- Polyethylene glycol (PEG)
- Chitosan
- Polylactic acid (PLA)
- Polyvinylidene fluoride (PVDF)
Correct Answer: Chitosan
Q5. A major limitation of polymeric nanoparticles is:
- Complete absence of burst release
- Potential cytotoxicity from residual solvents or degradation products
- Unlimited drug loading capacity
- Automatic regulatory approval
Correct Answer: Potential cytotoxicity from residual solvents or degradation products
Q6. Which formulation method is commonly used to prepare PLGA nanoparticles for hydrophobic drugs?
- Emulsion solvent evaporation
- Lyophilization without solvent
- Spray-freeze drying
- Hot-melt extrusion at room temperature
Correct Answer: Emulsion solvent evaporation
Q7. Which characterization technique provides information about polymer thermal transitions and crystallinity?
- Dynamic light scattering (DLS)
- Differential scanning calorimetry (DSC)
- Zeta potential analysis
- Ultraviolet-visible spectroscopy (UV-Vis)
Correct Answer: Differential scanning calorimetry (DSC)
Q8. Burst release in polymeric systems is primarily caused by:
- Uniform drug distribution in polymer core
- Drug adsorbed or located near particle surface
- Complete crosslinking of polymer chains
- High glass transition temperature above physiological temperature
Correct Answer: Drug adsorbed or located near particle surface
Q9. PEGylation of nanoparticles is used to:
- Increase aggregation in blood
- Reduce recognition by the reticuloendothelial system (RES)
- Increase positive surface charge for cell uptake
- Promote immediate renal clearance
Correct Answer: Reduce recognition by the reticuloendothelial system (RES)
Q10. Which release model describes drug release proportional to the square root of time, often for diffusion-controlled systems?
- Zero-order model
- Higuchi model
- First-order model
- Korsmeyer–Peppas model exclusively
Correct Answer: Higuchi model
Q11. In nanoprecipitation, particle formation is driven mainly by:
- Electrostatic precipitation of polymers
- Drug crystallization from a supersaturated melt
- Rapid solvent diffusion and polymer precipitation
- Thermal coagulation at high temperature
Correct Answer: Rapid solvent diffusion and polymer precipitation
Q12. Which factor DOES NOT significantly influence drug release rate from a polymer matrix?
- Polymer molecular weight
- Drug solubility in release medium
- Color of the polymer
- Polymer crystallinity
Correct Answer: Color of the polymer
Q13. Which polymer is widely used for long-acting injectable formulations and degrades into lactic and glycolic acid?
- PLGA
- Polyacrylamide
- Polycaprolactam
- Polyethylene
Correct Answer: PLGA
Q14. Zeta potential measurement primarily informs about:
- Drug chemical stability
- Surface charge and colloidal stability of particles
- Polymer melt flow index
- Degree of polymer crosslinking
Correct Answer: Surface charge and colloidal stability of particles
Q15. A limitation when scaling up polymer nanoparticle production is:
- Improved batch-to-batch uniformity
- Maintaining identical particle size and encapsulation efficiency
- Reduced regulatory scrutiny
- Unlimited solvent removal efficiency
Correct Answer: Maintaining identical particle size and encapsulation efficiency
Q16. Which crosslinking method is most likely to affect biocompatibility if residual agents remain?
- Ionic crosslinking using calcium ions
- Physical gelation by cooling
- Covalent crosslinking using glutaraldehyde
- Photo-crosslinking using biocompatible photoinitiators
Correct Answer: Covalent crosslinking using glutaraldehyde
Q17. Which property of a drug favors sustained release from a hydrophobic polymer matrix?
- High aqueous solubility
- Hydrophilicity and small molecular size
- High lipophilicity and low aqueous solubility
- Very high volatility
Correct Answer: High lipophilicity and low aqueous solubility
Q18. Mucoadhesive polymers enhance oral bioavailability by:
- Preventing drug absorption across mucosa
- Increasing residence time at absorption site
- Rapidly clearing from the GI tract
- Reducing drug solubility intentionally
Correct Answer: Increasing residence time at absorption site
Q19. Which analytical technique detects chemical interactions between drug and polymer?
- Infrared spectroscopy (FTIR)
- Dynamic light scattering (DLS)
- Laser diffraction particle sizing
- Conductivity measurement
Correct Answer: Infrared spectroscopy (FTIR)
Q20. Polymer crystallinity typically affects drug release by:
- Having no impact on diffusion
- Increasing diffusion pathways and accelerating release
- Decreasing chain mobility and slowing diffusion-controlled release
- Eliminating polymer degradation entirely
Correct Answer: Decreasing chain mobility and slowing diffusion-controlled release
Q21. Which is an advantage of nanoparticle-based targeted delivery?
- Guaranteed absence of off-target accumulation
- Potential for ligand-mediated targeting to specific cells
- Immediate and total systemic distribution
- Complete avoidance of immune system interaction
Correct Answer: Potential for ligand-mediated targeting to specific cells
Q22. The Korsmeyer–Peppas model is most useful for:
- Predicting drug solubility in water
- Determining release mechanism from polymeric systems
- Measuring particle zeta potential
- Estimating polymer molecular weight
Correct Answer: Determining release mechanism from polymeric systems
Q23. Which sterilization method can degrade some biodegradable polymers like PLGA?
- Gamma irradiation
- Filtration through 0.22 μm filter for nanoparticles
- Dry heat sterilization at low temperature
- Sterile aseptic processing avoiding sterilization
Correct Answer: Gamma irradiation
Q24. For ocular delivery, a desirable polymer property is:
- High irritancy and non-biodegradability
- Mucoadhesion and biocompatibility
- Rapid systemic clearance from eye surface
- Strong hydrophobicity causing precipitation
Correct Answer: Mucoadhesion and biocompatibility
Q25. Which statement about PEG is TRUE?
- PEG always causes severe immunogenicity
- PEGylation increases water solubility and circulation time
- PEG is highly crystalline and insoluble
- PEG accelerates rapid renal filtration of large particles
Correct Answer: PEGylation increases water solubility and circulation time
Q26. An advantage of polymeric microspheres over solutions is:
- Immediate peak plasma concentration only
- Ability to provide sustained release and reduce dosing frequency
- Higher risk of systemic toxicity always
- Elimination of the need for any formulation testing
Correct Answer: Ability to provide sustained release and reduce dosing frequency
Q27. Which factor would likely decrease the rate of polymer degradation in vivo?
- Higher polymer hydrophilicity
- Lower molecular weight
- Increased crystallinity
- Presence of hydrolytic enzymes
Correct Answer: Increased crystallinity
Q28. Surface functionalization of nanoparticles with targeting ligands primarily improves:
- Bulk polymer degradation rate
- Specific cell or tissue uptake
- Intrinsic drug chemical stability only
- Particle density without affecting targeting
Correct Answer: Specific cell or tissue uptake
Q29. A limitation related to regulatory approval of polymer-based systems is:
- Straightforward classification with no additional data
- Need for extensive safety, biodegradation, and residual solvent data
- Absence of any guidance documents from regulatory agencies
- Automatic approval if polymer is FDA-listed
Correct Answer: Need for extensive safety, biodegradation, and residual solvent data
Q30. Stability challenges of polymer-based formulations during storage often include:
- No change in particle size or drug stability ever
- Aggregation, polymer hydrolysis, and drug leakage
- Guaranteed prevention of microbial growth without preservatives
- Spontaneous improvement in encapsulation efficiency over time
Correct Answer: Aggregation, polymer hydrolysis, and drug leakage
